- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03493243
Teenagers After London Terrorist Attack (AVAL)
October 24, 2019 updated by: COULON Nathalie, University Hospital, Brest
AVAL Cohort Study First Step, Observational Study, After One Year
- Context: Since March 2012, several terrorist attacks have been perpetrated in France (Toulouse, Montauban, Paris, Nice ...). In March 2017, 53 french teenagers were victims in a terrorist attack in London (Westminster Bridge).
- Main goal = to estimate the psycho-traumatic impact and to describe cares and management of high school students, victims of the terrorist attack in London on 2017, March the 22nd.
- 3 secondary objectives: 1) Clinical (occurrence of Post Traumatic Stress Disorders or other disorders); 2) Epidemiological (risk factors for developing disorders, avoiding care); 3) Preventive and therapeutic.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Inclusion criterion: 53 teenagers of Saint-Joseph high school (Concarneau, France) directly exposed to the terrorist attack.
Methodology: self questionnaires and heterogenous questionnaires; descriptive statistics (means +/- standard deviations; search for a significant difference according to traumatic symptomatology)
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29200
- CHU
-
Brest, France, 29200
- HIA Hôpital d'Instruction des Armées Clermont Tonnerre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
- 53 Teenagers;
- Saint-Joseph high school (29)
- Directly exposed.
Description
Inclusion Criteria:
- 53 teenagers, from Concarneau (France) high school, directly exposed from London terrorist attack (22.03.2017).
Exclusion Criteria:
- All persons not directly exposed;
- Relatives of teenagers;
- 3 physically injured teenagers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Adolescents exposed
Only clinical questionnaires
|
2-hour clinical observation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD
Time Frame: One year after the terrorist attack (Day 1)
|
Post Traumatic Stress Disorder (Self-Questionnaire :Posttraumatic stress disorder checklist 5 )
|
One year after the terrorist attack (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical (occurence of Post Traumatic Stress Disorders or other disorders)
Time Frame: One year after the terrorist attack (Day 1)
|
Mini International Neuro-psychiatric Interview for children and adolescent
|
One year after the terrorist attack (Day 1)
|
Epidemiological (risk factors for developing disorders, avoiding care);
Time Frame: One year after the terrorist attack (Day 1)
|
LEC = Life Event checklist
|
One year after the terrorist attack (Day 1)
|
Preventive and therapeutic
Time Frame: One year after the terrorist attack (Day 1)
|
MINI = Mini International Neuropsychiatric Interview
|
One year after the terrorist attack (Day 1)
|
Epidemiological (risk factors for developing disorders, avoiding care);
Time Frame: One year after the terrorist attack (Day 1)
|
ALCES = Adolescent Life Change Event Scale
|
One year after the terrorist attack (Day 1)
|
Epidemiological (risk factors for developing disorders, avoiding care);
Time Frame: One year after the terrorist attack (Day 1)
|
EPS 10 = "Echelle de Provisions Sociales Abrégées";
|
One year after the terrorist attack (Day 1)
|
Epidemiological (risk factors for developing disorders, avoiding care);
Time Frame: One year after the terrorist attack (Day 1)
|
Whodas 2.0 = World Health Organization Disability Assessment Schedule
|
One year after the terrorist attack (Day 1)
|
Preventive and therapeutic
Time Frame: One year after the terrorist attack (Day 1)
|
Questionnaire about use of psychoactive substances
|
One year after the terrorist attack (Day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nathalie V COULON, MD PhD, CHU Brest
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2018
Primary Completion (Actual)
April 13, 2018
Study Completion (Actual)
April 13, 2018
Study Registration Dates
First Submitted
March 20, 2018
First Submitted That Met QC Criteria
April 9, 2018
First Posted (Actual)
April 10, 2018
Study Record Updates
Last Update Posted (Actual)
October 25, 2019
Last Update Submitted That Met QC Criteria
October 24, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AVAL (29BRC17.0248)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Secured email aval.france@chu-brest.fr
IPD Sharing Time Frame
6 months
IPD Sharing Access Criteria
aval.france@chu-brest.fr/
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University of ZurichCompletedPost Traumatic Stress Disorder (PTSD) | Complex Post-Traumatic Stress Disorder (CPTSD)Switzerland
-
University of NottinghamNottinghamshire Healthcare NHS Trust; Lincolnshire Partnership NHS Foundation...CompletedDomestic Violence | Trauma, Psychological | Post-Traumatic Stress Disorder in Children | Narrative Exposure Therapy | Post-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder ComplexUnited Kingdom
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
-
VA Greater Los Angeles Healthcare SystemUniversity of California, Los AngelesRecruitingPost-Traumatic Stress DisorderUnited States
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
University Hospital, GrenobleUniversity Grenoble AlpsNot yet recruitingChildhood Cancer | Adapted Physical ActivityFrance
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Cliniques universitaires Saint-Luc- Université...Fonds National de la Recherche ScientifiqueNot yet recruitingAlcohol Use Disorder
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States